Week 4 Part 2 - Using Microarrays for Diagnosis of Human Genetic Diseases Flashcards
Trisomy 21
Down syndrome Features: - poor immune function - developmental delay - intellectual disabilities - single palmar crease Increased risk of: - congenital heart disease - leukaemia - thyroid disorders
Microdeletion and Microduplication Syndromes
Hundreds of syndromes are known to be caused by small deletions or duplications that cannot be seen by conventional cytogenetics
Mostly detected by microarray, MLPA or FISH
Many are recurrent - occur in same location in the genome in many different patients
Low copy repeat (LCR) sequences can cause DNA to misalign at meiosis or mitosis and result in deletions or duplications
LCRs predispose the region to recurrent genomic rearrangements by non-allelic homologous recombination (NAHR)
DiGeorge Syndrome (22q11.2 Deletion Syndrome)
Most frequent contiguous gene deletion syndrome
Includes the TBX1 gene
Features:
- cardiac defects ~64% individuals (VSD in 23%)
- developmental delay ~70-90% individuals
- immune deficiency ~77% individuals (thymic hypoplasia)
- craniofacial features (ear anomalies, bulbous nose, micrognathia)
- cleft Palate/ palatal anomalies (~ 67% individuals)
- hypocalcemia (low calcium), secondary to hypoparathyroidism
22q11.2 Duplication Syndrome
This duplication is the reciprocal event to the 22q11.2 deletion
Highly variable phenotype - duplication is milder than deletion
Features include:
- mild to moderate intellectual disability
- delayed psychomotor development
- growth retardation
- hypotonia
- some abnormalities associated with 22q11.2 deletion including heart defects
This duplication is also found in unaffected individuals including parent
Variable expressivity and incomplete penetrance therefore LIKELY PATHOGENIC
Paternal UPD14 / Kagami-Ogata Syndrome
Large gestational age
Hypotonia
Feeding difficulties
Small bell shaped thorax with “coat hanger ribs”
Dysmorphic features: hairy forehead, full cheeks, protruding philtrum, micrognathia
Abdominal wall defects
Maternal and Paternal 15q11q13 Deletion
Maternal deletion = Angelman syndrome - developmental delay - don't speak much - floppy arms - wide mouth - widely spaced teeth - seizures Paternal deletion = Prader Willi Syndrome - developmental delay - hypotonia - feeding difficulties - after 2 years develop an obsession for food
15q11q13 Duplication Syndrome
Recurrent duplication to the deletion region seen in Angelman and Prader-Willi syndromes
Clinical features
- autism
- intellectual disability
- seizures
- developmental delays (including speech)
- hypotonia
- behavioural problems
Duplications are mostly maternally in origin and de novo (Pathogenic)
Paternally inherited duplication have a mild or no abnormal phenotype
PMP22 Gene on 17p12
17p12 duplication including the PMP22 gene causes Charcot Marie Tooth Type 1A (CMT1A)
Adult-onset progressive peripheral neuropathy (presents within first two decades of life)
CMT1A is characterised by distal symmetrical muscle weakness
PMP22 protein is produced predominantly by Schwann cells
It is critical to myelination in the peripheral nervous system (PNS)
PMP-22 duplication gives an increase in the protein which causes CMT1A
PMP-22 deletion gives a decrease in the protein which causes a milder peripheral neuropathy called hereditary neuropathy with liability to pressure palsies (HNPP)
Quality Control Checks
The quality control (QC) parameters required for sample acceptance:
- LogR standard deviation ≤ 0.16
- B allele standard deviation (BAF dev) ≤ 0.04
- call rates ≥ 0.99
Advantages of Microarray Analysis
Higher resolution that karyotype therefore higher diagnostic yield
Whole genome analysis
Tissue culture not needed
Potentially quicker than karyotype - urgents reported in 6-14 days
Some automation
Disadvantages/Limitations of Microarray Analysis
Unable to detect balanced rearrangements, heterodisomic UPD or small variants
Low level mosaicism can be missed (<10%)
No positional information for a duplication – do not know if tandem or transposed elsewhere in the genome
Can be time consuming to analyse and report
Many CNVs are novel with unknown clinical significance
Can detect incidental finding
Angelman Syndrome - Genetic Variation
70% maternal 15q11.2q13 deletion 3-7% paternal UPD15 3% imprinting defects 11% UBE3A variant 10% unknown Loss of maternally expressed genes
5p15 Deletion
Cri du Chat Syndrome Features: - speech delay - characteristic cry - facial dysmorphism - intellectual disability Pathogenic
11p15 Duplication
Paternally inherited 11p15 duplications are associated with Beckwith Wiedemann syndrome (BWS)
Clinically heterogeneous overgrowth syndrome
- increased risk of Wilms tumour
Pathogenic